Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

The New World Order: Current Developments in Challenging and Defending Patents in the PTAB

Summary

Speakers

Mark J. Abate

Related Content

Issue 44: PTAB Trial Tracker

Issue 43: PTAB Trial Tracker

Issue 42: PTAB Trial Tracker

Issue 41: PTAB Trial Tracker

Issue 40: PTAB Trial Tracker

Issue 39: PTAB Trial Tracker

Issue 38: PTAB Trial Tracker

Fintiv 2.0: USPTO Director Issues Guidance Softening Risk of Discretionary Denial

The Fate of the Therapeutic Dosing Regimen: Trends and Considerations in Validity Challenges to Dosing Patent Claims

Leading PTAB Partner Lori Gordon Joins Goodwin’s Intellectual Property Litigation Practice in Washington, DC

Biosimilars Patent Challenges at the PTAB: Update and Lessons Learned

Key PTAB Priorities And Changes Under Vidal (Law360)

Future Of PTAB Denials Left Open By 'Grab Bag' Of Proposals (Law360)

PTAB Permanently Altered By Fintiv, Even as Denials Plummet (Law360)

Louis Lobel and Sammy Tang to Participate in Leadership Council on Legal Diversity Programs

Goodwin Expands Washington, D.C. Litigation Team with Intellectual Property Partner Amadou Diaw

Patent Trial & Appeal Board